WallStSmart

MiniMed Group, Inc. Common Stock (MMED)vsPhreesia Inc (PHR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 523% more annual revenue ($2.89B vs $463.20M). MMED leads profitability with a -7.3% profit margin vs -116.0%. PHR earns a higher WallStSmart Score of 41/100 (D).

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0

PHR

Hold

41

out of 100

Grade: D

Growth: 8.0Profit: 2.0Value: 5.0Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MMED0 strengths · Avg: 0/10

No standout strengths identified

PHR2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
45.7%10/10

Revenue surging 45.7% year-over-year

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Areas to Watch

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

PHR4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$680.04M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-1.9%2/10

ROE of -1.9% — below average capital efficiency

Profit MarginProfitability
-116.0%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bull Case : PHR

The strongest argument for PHR centers on Revenue Growth, Price/Book. Revenue growth of 45.7% demonstrates continued momentum.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Bear Case : PHR

The primary concerns for PHR are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

MMED profiles as a turnaround stock while PHR is a hypergrowth play — different risk/reward profiles.

PHR is growing revenue faster at 45.7% — sustainability is the question.

PHR generates stronger free cash flow (12M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

PHR scores higher overall (41/100 vs 37/100) and 45.7% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Phreesia Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Phreesia, Inc. provides integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company is headquartered in Raleigh, North Carolina.

Want to dig deeper into these stocks?